|
Group I
|
Group II
|
p-value*
|
---|
(Cirrhosis)
|
(Cirrhosis and HCC)
|
---|
N (%)
|
45 (50.0 %)
|
45 (50.0 %)
| |
Age
|
58.68 ± 10.76
|
64.64 ± 7.73
|
0.003
|
Sex (F/M)
|
(1/49)
|
(0/50)
| |
Child-Pugh class
| | |
0.052
|
A
|
20 (44.4 %)
|
21 (45.6 %)
|
B
|
8 (17.8 %)
|
16 (35.6 %)
|
C
|
17 (37.8 %)
|
8 (17.8 %)
|
MELD scorea
|
14.04 ± 5.56
|
12.71 ± 4.25
|
0.205
|
BCLC Stageb
| | | |
0
| |
2 (4.4 %)
|
A
| |
19 (42.2 %)
|
B
| |
11 (24.4 %)
|
C
| |
7 (15.6 %)
|
D
| |
6 (13.3 %)
|
- *p - Value was calculated by using Student T test or χ2 test
- aModel for End-stage Liver Disease score
- bBarcelona Clinic Liver Cancer